Literature DB >> 7919333

Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth.

J R Keller1, S H Bartelmez, E Sitnicka, F W Ruscetti, M Ortiz, J M Gooya, S E Jacobsen.   

Abstract

Both transforming growth factor beta (TGF beta) and macrophage inflammatory protein 1 alpha (MIP-1 alpha) have been shown to be multifunctional regulators of hematopoiesis that can either inhibit or enhance the growth of hematopoietic progenitor cells (HPC). We report here the spectrum of activities of these two cytokines on different hematopoietic progenitor and stem cell populations, and whether these effects are direct or indirect. MIP-1 alpha enhances interleukin-3 (IL-3)/and granulocyte-macrophage colony-stimulating factor (GM-CSF)/induced colony formation of normal bone marrow progenitor cells (BMC) and lineage-negative (Lin-) progenitors, but has no effect on G-CSF or CSF-1/induced colony formation. Similarly, TGF beta enhances GM-CSF/induced colony formation of normal BMC and Lin- progenitors. In contrast, TGF beta inhibits IL-3/ and CSF-1/induced colony formation of Lin- progenitors. The effects of MIP-1 alpha and TGF beta on the growth of Lin- progenitors were direct and correlate with colony formation in soft agar. Separation of the Lin- cells into Thy-1 and Thy-1lo subsets showed that the growth of Thy-1lo Lin- cells is directly inhibited by MIP-1 alpha and TGF beta regardless of the cytokine used to stimulate growth (IL-3), GM-CSF, or CSF-1). In contrast, two other stem cell populations (0% to 15% Höechst 33342/Rhodamine 123 [Hö/Rh123] and Lin-Sca-1+ cells) were markedly inhibited by TGF beta and unaffected by MIP-1 alpha. Furthermore, MIP-1 alpha has no effect on high proliferative potential colony-forming cells 1 or 2 (HPP-CFC/1 or /2) colony formation in vitro, whereas TGF beta inhibits both HPP-CFC/1 and HPP-CFC/2. Thus, MIP-1 alpha and TGF beta are direct bidirectional regulators of HPC growth, whose effects are dependent on other growth factors present as well as the maturational state of the HPC assayed. The spectrum of their inhibitory and enhancing activities shows overlapping yet distinct effects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7919333

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Vitreous body affects activation and maturation of monocytes into macrophages.

Authors:  R Osuský; S M Walker; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-10       Impact factor: 3.117

2.  Trauma inhibits erythroid burst-forming unit and granulocyte-monocyte colony-forming unit growth through the production of TGF-beta1 by bone marrow stroma.

Authors:  J C Wu; D H Livingston; C J Hauser; E A Deitch; P Rameshwar
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

Review 3.  Transforming growth factor beta, pleiotropic regulator of hematopoietic stem cells: potential physiological and clinical relevance.

Authors:  F W Ruscetti; S H Bartelmez
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

4.  Modulation of Hematopoietic Chemokine Effects In Vitro and In Vivo by DPP-4/CD26.

Authors:  Hal E Broxmeyer; Maegan Capitano; Timothy B Campbell; Giao Hangoc; Scott Cooper
Journal:  Stem Cells Dev       Date:  2016-03-30       Impact factor: 3.272

5.  Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice.

Authors:  H E Broxmeyer; S Cooper; N Hague; L Benninger; A Sarris; K Cornetta; S Vadhan-Raj; P Hendrie; C Mantel
Journal:  Ann Hematol       Date:  1995-11       Impact factor: 3.673

6.  Continuous infusion of macrophage inflammatory protein MIP-1alpha enhances leucocyte recovery and haemopoietic progenitor cell mobilization after cyclophosphamide.

Authors:  E Marshall; L B Woolford; B I Lord
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Dominant myelopoietic effector functions mediated by chemokine receptor CCR1.

Authors:  H E Broxmeyer; S Cooper; G Hangoc; J L Gao; P M Murphy
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

8.  HCC-1, a novel chemokine from human plasma.

Authors:  P Schulz-Knappe; H J Mägert; B Dewald; M Meyer; Y Cetin; M Kubbies; J Tomeczkowski; K Kirchhoff; M Raida; K Adermann; A Kist; M Reinecke; R Sillard; A Pardigol; M Uguccioni; M Baggiolini; W G Forssmann
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.